Sickle Cell

Sebastien Beauzile Is Pain-Free After Lyfgenia While a $3.1 Million Sickle Cell Therapy Still Barely Reaches Patients
Health News

Sebastien Beauzile Is Pain-Free After Lyfgenia While a $3.1 Million Sickle Cell Therapy Still Barely Reaches Patients

Sebastien Beauzile left sickle cell pain behind after Lyfgenia at Cohen Children's. Fewer than 40 patients have been infused, and the $3.1 million price still blocks the door.
Bouton retour en haut de la page